First Trust Advisors’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,378
Closed -$655K 2707
2025
Q2
$655K Sell
11,378
-50,064
-81% -$2.83M ﹤0.01% 2188
2025
Q1
$3.58M Sell
61,442
-49,540
-45% -$3.38M ﹤0.01% 1497
2024
Q4
$8.94M Sell
110,982
-915
-0.8% -$78.2K 0.01% 1099
2024
Q3
$8.97M Buy
111,897
+560
+0.5% +$39.8K 0.01% 1079
2024
Q2
$6.8M Buy
111,337
+33,051
+42% +$1.97M 0.01% 1140
2024
Q1
$3.87M Buy
78,286
+19,369
+33% +$922K ﹤0.01% 1426
2023
Q4
$2.47M Buy
58,917
+9,380
+19% +$319K ﹤0.01% 1627
2023
Q3
$1.63M Buy
+49,537
New +$1.69M ﹤0.01% 1768
2023
Q2
Sell
-76,923
Closed -$2.18M 2427
2023
Q1
$2.18M Sell
76,923
-87,391
-53% -$3.08M ﹤0.01% 1653
2022
Q4
$6.83M Buy
164,314
+88,141
+116% +$3.78M 0.01% 1076
2022
Q3
$3.16M Buy
76,173
+21,326
+39% +$851K ﹤0.01% 1427
2022
Q2
$1.79M Buy
+54,847
New +$2M ﹤0.01% 1768

Other funds holding PRCT

First Trust Advisors's PRCT Position: Q3 2025 in Review

First Trust Advisors sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 11,378 shares — an estimated $655K sold.

First Trust Advisors first reported a position in PRCT in Q2 2022 and held it in 12 quarters. The position peaked at $8.97M in Q3 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • First Trust Advisors reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • First Trust Advisors sold 11,378 Procept Biorobotics shares in Q3 2025, an estimated $655K.
  • First Trust Advisors first reported a position in Procept Biorobotics in Q2 2022 and held it in 12 quarters.
  • First Trust Advisors's Procept Biorobotics position peaked at $8.97M in Q3 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on First Trust Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.